-
ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-144-section-2.pdf
January 01, 2020 - And Unspecified Effects Of
External Causes (990-995)
9941 Drowning/nonfatal submer
99555 Shaken infant
-
effectivehealthcare.ahrq.gov/health-topics/tay-sachs-disease
-
effectivehealthcare.ahrq.gov/system/files/docs/headaches-pregnancy-topic-brief.pdf
January 01, 2019 - Medications in pregnancy may cause
fetal and infant harms.
2b.
-
effectivehealthcare-admin.ahrq.gov/system/files/docs/headaches-pregnancy-topic-brief.pdf
January 01, 2019 - Medications in pregnancy may cause
fetal and infant harms.
2b.
-
effectivehealthcare-admin.ahrq.gov/products/hepatitis-c-treatment-adherence/research-protocol
December 01, 2019 - transmitted through needle-stick injuries and via vertical transmission from an infected mother to infant
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/intimate-partner-violence-and-abuse-of-elderly-and-vulnerable-adults-screening
October 23, 2018 - pregnancy is associated with preterm birth and low birth weight 6 and adverse effects on maternal and infant
-
effectivehealthcare.ahrq.gov/health-topics/gaucher-disease/
-
effectivehealthcare.ahrq.gov/health-topics/ear-disorders/
-
effectivehealthcare.ahrq.gov/health-topics/gerd/
-
www.qualitymeasures.ahrq.gov/workingforquality/events/webinar-best-practices-to-improve-community-health.html
November 01, 2016 - We continue to rank low—or least low when compared to other developed countries—in infant mortality;
-
www.healthcare411.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-133-section-2-tech-specs.pdf
January 01, 2011 - Eligible Population
Women age 10- 65 years who are pregnant and deliver an infant, whether living or
-
www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-133-section-2-tech-specs.pdf
January 01, 2011 - Eligible Population
Women age 10- 65 years who are pregnant and deliver an infant, whether living or
-
www.monahrq.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-133-section-2-tech-specs.pdf
January 01, 2011 - Eligible Population
Women age 10- 65 years who are pregnant and deliver an infant, whether living or
-
www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-133-section-2-tech-specs.pdf
January 01, 2011 - Eligible Population
Women age 10- 65 years who are pregnant and deliver an infant, whether living or
-
www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-243-fullreport.pdf
August 01, 2019 - Population – infants (29 days to 1 year) (specify age range): Yes; all ages in this
range.
q.
-
www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-133-section-2-tech-specs.pdf
January 01, 2011 - Eligible Population
Women age 10- 65 years who are pregnant and deliver an infant, whether living or
-
www.healthcare411.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-243-fullreport.pdf
August 01, 2019 - Population – infants (29 days to 1 year) (specify age range): Yes; all ages in this
range.
q.
-
www.monahrq.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-243-fullreport.pdf
August 01, 2019 - Population – infants (29 days to 1 year) (specify age range): Yes; all ages in this
range.
q.
-
www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-243-fullreport.pdf
August 01, 2019 - Population – infants (29 days to 1 year) (specify age range): Yes; all ages in this
range.
q.
-
www.cahps.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-243-fullreport.pdf
August 01, 2019 - Population – infants (29 days to 1 year) (specify age range): Yes; all ages in this
range.
q.